Drugs / recombinant fowlpox-B7.1 vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00030693 | Dec 2001 → Apr 2010 | cancer of unknown primary site | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant fowlpox-B7.1 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00030693 ↗ |
| Known as | rF-B7.1 vaccine | “rF-B7.1 vaccine” NCT00030693 ↗ |
| Modality | Vaccine | “rF-B7.1 vaccine” NCT00030693 ↗ |
| Route | Other | “Given intratumorally” NCT00030693 ↗ |